Active-ingredient Dossier
Medium Chain Triglycerides
Active-ingredient Dossier for Medium Chain Triglycerides (lipid supplement). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: NeuroMed
- Brand: SMOFKABIVEN
- Brand: FINOMEL
- Brand: SMOFlipid
- Brand: Biowell
- Therapeutic area: Other
- Therapeutic area: Complementary Medicine
- Therapeutic area: Gastroenterology
What is
Medium Chain Triglycerides Medium Chain Triglycerides is a lipid supplement.
Australian brands containing
Medium Chain Triglycerides — NeuroMed — SMOFKABIVEN — FINOMEL — SMOFlipid — Biowell
Therapeutic areas
Medium Chain Triglycerides is registered in complementary medicine (2 brands), gastroenterology (2 brands), and other therapeutic areas (1 brand).
Sponsor landscape
Medium Chain Triglycerides is marketed by four sponsors: Fresenius Kabi, PNHE, Baxter Healthcare, and PharmSky Research.
PBS and regulatory activity
The latest PBAC outcome for Medium Chain Triglycerides was recorded on 1 November 2015, and the latest AusPAR was issued on 20 December 2011. One brand has a PBAC outcome on record, and one brand has an AusPAR on record.